Building stronger AI foundations for drug discovery

This resource explores how the success of artificial intelligence in drug discovery depends on the quality, structure, and governance of underlying data. It highlights how fragmented, incomplete, or biased datasets can limit AI performance, and outlines approaches to improve data readiness through FAIR principles, standardization, and collaborative frameworks such as federated learning.

Explore how platforms like Signals One™ enable researchers to unify and structure data across workflows, supporting more reliable AI‑driven insights and accelerating decision‑making in drug development.